<?xml version="1.0" encoding="UTF-8"?>
<p>Ulinastatin is a serin protease inhibitor with anti-inflammatory effects approved in China and Japan for the treatment of acute pancreatitis and sepsis (
 <xref rid="B123" ref-type="bibr">123</xref>). There is an ongoing clinical trial (NCT04393311) that is testing the safety and efficacy of ulinastatin compared to placebo in COVID-19 patients.
</p>
